Our recent study on ASUC.
Colectomy at
Discharge-8%
1 yr-13.5%
3yr -16.1%
5yr- 17.4%
Steroid responders and non-responders have similar outcomes.
Day-3 Oxford criteria remain relevant in post biologic era
@vipuljairath @virgisolitano
academic.oup.com/ecco-jcc/ad…
Sudheer Kumar Vuyyuru retweeted
Development and external validation of an endoscopic and histologic pouchitis assessment tool: the Atlantic Pouchitis Index
Congrats to @RocioSedanoMD for leading this over the last 5 years and to all collaborators for their guidance and input. pubmed.ncbi.nlm.nih.gov/4067…
Sudheer Kumar Vuyyuru retweeted
Available online from today, the latest @BritSocGastro IBD guidelines. Thank you to all who contributed. gut.bmj.com/content/74/Suppl…
Sudheer Kumar Vuyyuru retweeted
Replying to @BritSocGastro
@BritSocGastro IBD Guidelines 2025 - out now! : gut.bmj.com/content/74/Suppl…
Sudheer Kumar Vuyyuru retweeted
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease. Much needed effort to standardize the approach to steroids in trials lead by @ChrisMa_YYC with global contributions! pubmed.ncbi.nlm.nih.gov/4044…
Sudheer Kumar Vuyyuru retweeted
Department of Medicine Residents Research Day. This year we had 95 abstracts from our trainees sharing their research from basic science, clinical research, QI and education research. Thanks to all of our trainees and faculty who made this a success @SchulichMedDent @WesternU
Excited to share that I’ve completed the IBUS training in intestinal ultrasound for IBD. Grateful to learn this new skill #IBUS
Thanks to Dr.Siwar Albashir, Dr.Prowse at McMasters and @GordonMoranIBD @drgauraang @vipuljairath for encouragement and support @BowelUltrasound
Check out our recent comprehensive review on IL23 inhibitors in CD
@vipuljairath @SpringerNature
#IL23p19, #Crohn’s disease #biologics
pubmed.ncbi.nlm.nih.gov/4032…
Sudheer Kumar Vuyyuru retweeted
📢 Join us on Tuesday, May 20th at 1:00 PM CET for another exclusive IBUS SciCom Webinar on "Standardized IUS Scoring in IBD" with Dr. Gabriele Dragoni, Dr. Chris Ma and Dr. Christoph Teichert
👉 Visit the IBUS website for more details and to register: ibus-group.org/event/webinar…
Glad to share our recently published systematic review and meta analysis on ASUC.
@vipuljairath @alimentiv
pubmed.ncbi.nlm.nih.gov/4033…
Sudheer Kumar Vuyyuru retweeted
💥Our latest on how AI is revolutionizing IBD CTs!💥 AI is boosting patient recruitment, trial efficiency, personalized ttm, endpoint assessment & tackling key ethical & reg challenges👇@vipuljairath @virgisolitano @chrisma_yyc @olga_nardone @IBDologist journals.sagepub.com/doi/10.…
Sudheer Kumar Vuyyuru retweeted
"Unable To Accept...": Leading Industrialists Remember #RatanTata
🖇️ ndtv.com/india-news/ratan-ta…
Sudheer Kumar Vuyyuru retweeted
Tough cases in IBD - spirited discussion from our expert panel. @IBDMD @SeowCynthia @MatthieuAllez @vipuljairath @guthealthmd @ScopeCanMD
Sudheer Kumar Vuyyuru retweeted
How often during a colonoscopy in a patient w #CD could we have missed lesions that would have led to a change in therapy?
I’ve wondered about this many times @virgisolitano addresses it in her 📄
🔍 22.3% had lesions proximal to the TI
🔍 24.5% SB skip lesions in the ileum
🔍 10.4% had strictures
@vipuljairath @IBDJournals
academic.oup.com/ibdjournal/…
Sudheer Kumar Vuyyuru retweeted
New in UEG Journal
🆕 Prevalence of Complications in IBD Detected by Cross-Sectional Imaging
✴️ 33.2% stricturing complications in CD patients.
📊 10.6% fistulizing complications in CD patients.
✴️ Imaging identified EIMs in 7.4% of IBD patients.
🔗 doi.org/10.1002/ueg2.12635
Sudheer Kumar Vuyyuru retweeted
The first #IBUS Regional Hybrid Module 1 Workshop in London was a great success. Thank you to all participants and faculty members for your contribution!
Here is a recap of Day 2.
#IUS #Ultrasound #Workshop
Glad to share first stem cell study in Perianal CD from India @aiims_newdelhi
4yr of great team effort led by Prof Vineet Ahuja
MSCs are effective and safe
Valuable Tx for PFCD with limited options
Proud to be part of the team
@BhaskarK_Dr @DrPeeyushK
link.springer.com/article/10…
























